{"id":"clm_CC510D3CC49D","entity":"regeneron-pharmaceuticals","predicate":"shares_outstanding","value":"91,779,465 shares","value_json":{"fy":2011,"accn":"0001206774-12-000709","form":"10-K","filed":"2012-02-21","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2012-02-10","valid_to":"2012-04-11","published":"2012-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Regeneron Pharmaceuticals shares outstanding: 91,779,465 shares\", as of 2012-02-10 (until 2012-04-11). Claim clm_CC510D3CC49D, https://asof.is/claim/clm_CC510D3CC49D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm.","url":"https://asof.is/claim/clm_CC510D3CC49D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_577DFD723982","supersedes":["clm_1AE57BD8CE95"],"first_seen_at":"2026-11-08T17:08:55.512322+00:00","updated_at":"2026-11-08T17:09:02.679946+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-21T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-21"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}